Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
LinkedIn:
Twitter:
Media Releases
Aug 2, 2022 1:55 PM ET
Jul 27, 2022 11:25 AM ET
Jul 25, 2022 1:00 PM ET
Jul 20, 2022 10:20 AM ET
Jul 14, 2022 2:00 PM ET
- 1 of 26
- next ›
Recent Video
Jun 27, 2022 1:00 PM ET |
Jun 23, 2022 11:30 AM ET |
Jun 21, 2022 12:15 PM ET |
Recent Audio
Mar 10 |